Monitoring Agency Report for the quarter ended September 30, 2025
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2025 to the stock exchanges, as required under SEBI regulations. Monitoring Agency Reports are filed periodically by companies that have raised capital through public issues, rights issues, or preferential allotments, to track whether the funds raised are being deployed in line with the stated objectives disclosed at the time of the issue. The filing itself is a routine compliance submission and does not, by itself, indicate any positive or negative development. Investors should review the actual report (typically available on the company's investor page or stock exchange website) to see specific details on amount raised, amount deployed, and any deviations from the original purpose of issuance.
This is a routine regulatory disclosure with no immediate material impact on the stock price. Investors who hold the stock based on a previous fund-raise should check the report for confirmation that proceeds are being used as originally promised.